Pro-life CEO predicts Trump FDA nominee could bring renewed scrutiny to abortion drug risks
Top Story
Archived
•
August 25, 2026
•
Trump's FDA nominee Heidi Overton could bring renewed scrutiny to mifepristone, says Americans United for Life CEO who calls her a "pro-life" pick.
Source: FoxNews | https://feeds.feedburner.com/foxnews/latest - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



